Clostridium difficile Detection, PCR Test detects C. difficile DNA in stool to diagnose intestinal infection accurately.
The purpose of this test is to:
The Clostridium difficile Detection, PCR Test is a highly sensitive molecular test that detects the toxin-producing genes of Clostridioides difficile (C. difficile) in a stool sample using Polymerase Chain Reaction (PCR) technology. This test helps diagnose C. difficile infection (CDI), a common cause of antibiotic-associated diarrhea and infectious colitis, by identifying bacteria capable of producing disease-causing toxins.
Healthcare providers commonly recommend this test for individuals with persistent watery diarrhea, abdominal pain, fever, nausea, dehydration, or diarrhea that develops during or after antibiotic therapy.
Furthermore, the PCR test offers high sensitivity and specificity, allowing for the rapid detection of toxin-producing C. difficile strains, even when only a small amount of bacterial DNA is present.
The Clostridium difficile Detection, PCR Test is often performed alongside C. difficile Toxin A & B and GDH testing, Stool Routine Examination, Stool Culture, Fecal Calprotectin, Occult Blood Test, and other gastrointestinal investigations to provide a comprehensive evaluation of infectious diarrhea.
The test detects the DNA of toxin-producing Clostridioides difficile in a stool sample. It helps diagnose active C. difficile infection, a major cause of antibiotic-associated diarrhea and infectious colitis.
No fasting is required. A fresh stool sample should be collected in a clean, sterile container as instructed by your healthcare provider or the laboratory. Inform your healthcare provider about any recent antibiotic use or current medications, as this information helps with result interpretation.
A positive result indicates that toxin-producing Clostridioides difficile DNA has been detected in the stool sample. This suggests the presence of the bacteria, but the result should always be interpreted along with your symptoms, as some individuals may carry the bacteria without having active disease. Your healthcare provider will determine whether treatment or additional evaluation is required based on your overall clinical condition.